Slovak Drug Authority Recalls Heart Medication From Market

Slovakia's State Institute for Drug Control, the national authority responsible for regulating pharmaceuticals, has ordered a recall of a heart medication from the market. The institute assured the public that patient care will not be disrupted by the withdrawal, indicating that alternative treatments or supplies remain available. Such recalls are typically initiated when concerns arise over quality, safety, or compliance with regulatory standards.